166 related articles for article (PubMed ID: 21099359)
1. BRCA1 modulates the expression of hnRNPA2B1 and KHSRP.
Santarosa M; Del Col L; Viel A; Bivi N; D'Ambrosio C; Scaloni A; Tell G; Maestro R
Cell Cycle; 2010 Dec; 9(23):4666-73. PubMed ID: 21099359
[TBL] [Abstract][Full Text] [Related]
2. Loss of hnRNPA2B1 inhibits malignant capability and promotes apoptosis via down-regulating Lin28B expression in ovarian cancer.
Yang Y; Wei Q; Tang Y; Yuanyuan Wang ; Luo Q; Zhao H; He M; Wang H; Zeng Q; Lu W; Xu J; Liu T; Yi P
Cancer Lett; 2020 Apr; 475():43-52. PubMed ID: 32006618
[TBL] [Abstract][Full Text] [Related]
3. Fyn requires HnRNPA2B1 and Sam68 to synergistically regulate apoptosis in pancreatic cancer.
Chen ZY; Cai L; Zhu J; Chen M; Chen J; Li ZH; Liu XD; Wang SG; Bie P; Jiang P; Dong JH; Li XW
Carcinogenesis; 2011 Oct; 32(10):1419-26. PubMed ID: 21642356
[TBL] [Abstract][Full Text] [Related]
4. RNA-binding protein KHSRP promotes tumor growth and metastasis in non-small cell lung cancer.
Yan M; Sun L; Li J; Yu H; Lin H; Yu T; Zhao F; Zhu M; Liu L; Geng Q; Kong H; Pan H; Yao M
J Exp Clin Cancer Res; 2019 Nov; 38(1):478. PubMed ID: 31775888
[TBL] [Abstract][Full Text] [Related]
5. Integration of BRCA1-mediated miRNA and mRNA profiles reveals microRNA regulation of TRAF2 and NFκB pathway.
Tanic M; Zajac M; Gómez-López G; Benítez J; Martínez-Delgado B
Breast Cancer Res Treat; 2012 Jul; 134(1):41-51. PubMed ID: 22167321
[TBL] [Abstract][Full Text] [Related]
6. Inhibition of KHSRP sensitizes colorectal cancer to 5-fluoruracil through miR-501-5p-mediated ERRFI1 mRNA degradation.
Pan R; Cai W; Sun J; Yu C; Li P; Zheng M
J Cell Physiol; 2020 Feb; 235(2):1576-1587. PubMed ID: 31313286
[TBL] [Abstract][Full Text] [Related]
7. KH-Type Splicing Regulatory Protein Controls Colorectal Cancer Cell Growth and Modulates the Tumor Microenvironment.
Caiazza F; Oficjalska K; Tosetto M; Phelan JJ; Noonan S; Martin P; Killick K; Breen L; O'Neill F; Nolan B; Furney S; Power R; Fennelly D; Craik CS; O'Sullivan J; Sheahan K; Doherty GA; Ryan EJ
Am J Pathol; 2019 Oct; 189(10):1916-1932. PubMed ID: 31404541
[TBL] [Abstract][Full Text] [Related]
8. KH-type splicing regulatory protein (KHSRP) contributes to tumorigenesis by promoting miR-26a maturation in small cell lung cancer.
Tong L; Luo Y; Wei T; Guo L; Wang H; Zhu W; Zhang J
Mol Cell Biochem; 2016 Nov; 422(1-2):61-74. PubMed ID: 27644194
[TBL] [Abstract][Full Text] [Related]
9. SUMO1 modification of KHSRP regulates tumorigenesis by preventing the TL-G-Rich miRNA biogenesis.
Yuan H; Deng R; Zhao X; Chen R; Hou G; Zhang H; Wang Y; Xu M; Jiang B; Yu J
Mol Cancer; 2017 Oct; 16(1):157. PubMed ID: 29020972
[TBL] [Abstract][Full Text] [Related]
10. Downregulation of BRCA1 protein in BCR-ABL1 leukemia cells depends on stress-triggered TIAR-mediated suppression of translation.
Podszywalow-Bartnicka P; Wolczyk M; Kusio-Kobialka M; Wolanin K; Skowronek K; Nieborowska-Skorska M; Dasgupta Y; Skorski T; Piwocka K
Cell Cycle; 2014; 13(23):3727-41. PubMed ID: 25483082
[TBL] [Abstract][Full Text] [Related]
11. HNRNPA2B1 Is a Mediator of m(6)A-Dependent Nuclear RNA Processing Events.
Alarcón CR; Goodarzi H; Lee H; Liu X; Tavazoie S; Tavazoie SF
Cell; 2015 Sep; 162(6):1299-308. PubMed ID: 26321680
[TBL] [Abstract][Full Text] [Related]
12. Integrative Analysis of NSCLC Identifies LINC01234 as an Oncogenic lncRNA that Interacts with HNRNPA2B1 and Regulates miR-106b Biogenesis.
Chen Z; Chen X; Lei T; Gu Y; Gu J; Huang J; Lu B; Yuan L; Sun M; Wang Z
Mol Ther; 2020 Jun; 28(6):1479-1493. PubMed ID: 32246902
[TBL] [Abstract][Full Text] [Related]
13. Differing effects of breast cancer 1, early onset (BRCA1) and ataxia-telangiectasia mutated (ATM) mutations on cellular responses to ionizing radiation.
Mamon HJ; Dahlberg W; Azzam EI; Nagasawa H; Muto MG; Little JB
Int J Radiat Biol; 2003 Oct; 79(10):817-29. PubMed ID: 14630541
[TBL] [Abstract][Full Text] [Related]
14. Diverse roles of the nucleic acid-binding protein KHSRP in cell differentiation and disease.
Briata P; Bordo D; Puppo M; Gorlero F; Rossi M; Perrone-Bizzozero N; Gherzi R
Wiley Interdiscip Rev RNA; 2016; 7(2):227-40. PubMed ID: 26708421
[TBL] [Abstract][Full Text] [Related]
15. Binding of DAZAP1 and hnRNPA1/A2 to an exonic splicing silencer in a natural BRCA1 exon 18 mutant.
Goina E; Skoko N; Pagani F
Mol Cell Biol; 2008 Jun; 28(11):3850-60. PubMed ID: 18391021
[TBL] [Abstract][Full Text] [Related]
16. Gene expression profiles of BRCA1-linked, BRCA2-linked, and sporadic ovarian cancers.
Jazaeri AA; Yee CJ; Sotiriou C; Brantley KR; Boyd J; Liu ET
J Natl Cancer Inst; 2002 Jul; 94(13):990-1000. PubMed ID: 12096084
[TBL] [Abstract][Full Text] [Related]
17. Genomic signature of BRCA1 deficiency in sporadic basal-like breast tumors.
Joosse SA; Brandwijk KI; Mulder L; Wesseling J; Hannemann J; Nederlof PM
Genes Chromosomes Cancer; 2011 Feb; 50(2):71-81. PubMed ID: 21104783
[TBL] [Abstract][Full Text] [Related]
18. Identification of miR-10b, miR-26a, miR-146a and miR-153 as potential triple-negative breast cancer biomarkers.
Fkih M'hamed I; Privat M; Ponelle F; Penault-Llorca F; Kenani A; Bignon YJ
Cell Oncol (Dordr); 2015 Dec; 38(6):433-42. PubMed ID: 26392359
[TBL] [Abstract][Full Text] [Related]
19. Splicing factor hnRNPA2B1 contributes to tumorigenic potential of breast cancer cells through STAT3 and ERK1/2 signaling pathway.
Hu Y; Sun Z; Deng J; Hu B; Yan W; Wei H; Jiang J
Tumour Biol; 2017 Mar; 39(3):1010428317694318. PubMed ID: 28351333
[TBL] [Abstract][Full Text] [Related]
20. Altered expression of BRCA1, BRCA2, and a newly identified BRCA2 exon 12 deletion variant in malignant human ovarian, prostate, and breast cancer cell lines.
Rauh-Adelmann C; Lau KM; Sabeti N; Long JP; Mok SC; Ho SM
Mol Carcinog; 2000 Aug; 28(4):236-46. PubMed ID: 10972993
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
